September 11, 2009

12:00 noon

Registration Opens/Lunch (provided)

1:00 p.m.

Welcome and Introductions
James N. George, MD, Program Co-Chair
Past President, American Society of Hematology

Douglas B. Cines, MD, Program Co-Chair

1:10 p.m.

Acute Lymphoblastic Leukemia (ALL)
Dan Douer, MD
University of Southern California

1:50 p.m.

Chronic Myeloid Leukemia (CML)
Michael J. Mauro, MD
Oregon Health and Science University

2:30 p.m.

Acute Myeloid Leukemia (AML)
Martin S. Tallman, MD
Northwestern University

3:10 p.m.

Panel Discussion

3:25 p.m.

Break and Exhibits Open

3:45 p.m.

Platelet Disorders: Idiopathic Thrombocytopenia (ITP)
Douglas B. Cines, MD
University of Pennsylvania Hospital

4:25 p.m.

Platelet Disorders: Heparin-Induced Thrombocytopenia (HIT)
Gowthami Arepally, MD
Duke University Medical Center

5:05 p.m.

Platelet Disorders: Thrombotic Thrombocytopenic Purpura (TTP)
James N. George, MD
University of Oklahoma

5:45 p.m.

Panel Discussion

6:00 p.m.

Welcome Reception and Exhibits
All Speakers and Attendees

September 12, 2009

7:00 a.m.

Breakfast With the Experts
All Speakers and Attendees

8:00 a.m.

Announcements and Introductions
Martin S. Tallman, MD, Program Co-Chair

8:05 a.m.

Practice Update
James N. George, MD
Past President, American Society of Hematology

8:15 a.m.

Hodgkin Lymphoma
Nancy L. Bartlett, MD
Washington University

8:55 a.m.

Follicular Lymphoma
Peter McLaughlin, MD
The University of Texas M. D. Anderson Cancer Center

9:35 a.m.

Diffuse Large B-Cell Lymphoma
Laurie Sehn, MD
British Columbia Cancer Agency

10:15 a.m.

Break and Exhibits Open

10:35 a.m.

T-Cell Lymphoma
Ranjana Advani, MD
Stanford University

11:15 a.m.

Mantle Cell Lymphoma
Steven H. Bernstein, MD
University of Rochester

11:55 a.m.

Panel Discussion

12:15 p.m.

Lunch (provided) and Exhibits Open

1:15 p.m.

Marginal Zone and Lymphoplasmacytic Lymphomas
Sonali Smith, MD
University of Chicago

1:55 p.m.

Stem Cell Transplantation for Lymphoma
Hillard M. Lazarus, MD
University Hospitals Case Medical Center

2:35 p.m.

Break

2:50 p.m.

Myeloma: Management Transplant-Eligible Patients
Robert Z. Orlowski, MD, PhD
MD Anderson Cancer Center

3:30 p.m.

Myeloma: Management Transplant-Ineligible Patients
Donna E. Reece, MD
Princess Margaret Hospital

4:10 p.m.

Panel Discussion

4:30 p.m.

Symposium Adjourned